Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02955264 · ClinicalTrials.gov registry record · NA
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02955264 is a NA study that has completed, run by Tulane University. The registered enrollment target is 8 participants.
The verdict
NCT02955264, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this study is to better characterize the metabolic alterations and sugar structure alterations (glycosylation abnormalities) in patients diagnosed with Congenital Disorders of Glycosylation. The investigators aim to assess the safety and tolerability of oral galactose treatment in a small pilot group of Congenital Disorders of Glycosylation patients. The investigators will also determine the relationship between simple milk sugar intake (galactose dose) in the diet and the blood and urine markers of protein glycosylation abnormalities.
Interventions
- DIETARY_SUPPLEMENT D-Galactose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02955264
The ClinicalTrials.gov registry entry for NCT02955264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-Galactose is the first listed.
NCT02955264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02955264 about?
NCT02955264 is a clinical study titled "Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation". The goal of this study is to better characterize the metabolic alterations and sugar structure alterations (glycosylation abnormalities) in patients diagnosed with Congenital Disorders of Glycosylation. The investigators aim to assess the safety and tolerability of oral galactose treatment in a smal...
What is the current status of trial NCT02955264?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-07. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02955264?
The interventions under investigation include: D-Galactose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02955264?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.